Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Undefined

ABSTRACT: Systematic study of COVID early reinfections and persistence

PROVIDER: PRJEB56460 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR10307500_1.fastq.gz	Fastqsanger.gz
	ERR10307500_2.fastq.gz	Fastqsanger.gz
	ERR10307501_1.fastq.gz	Fastqsanger.gz
	ERR10307501_2.fastq.gz	Fastqsanger.gz
	ERR10307502_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

undefined

Project description:Validation study of covid sequencing from wastewater

| PRJEB53222 | ENA

undefined

Project description:Retrospective WGS study of Sotrovimab resistance acquisition in COVID samples

| PRJEB60088 | ENA

undefined

Project description:Surveillance Covid-Mexico-Langebio

| PRJEB57299 | ENA

undefined

Project description:Microbiome analysis for wastewater surveillance during COVID-19

| PRJEB51306 | ENA

undefined

Project description:Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T cell response

| PRJEB57236 | ENA

undefined

Project description:mNGS SLE study

| PRJEB60557 | ENA

undefined

Project description:MIRI RNA study

| PRJEB59007 | ENA

Unresolved Immune Dysfunction is Lethal in Both COVID-19 and non-COVID-19 Sepsis

Project description:In this prospective observational cohort study, we found transcriptional evidence that persistent immune dysfunction was associated with 28-day mortality in both COVID-19 and non-COVID-19 septic patients. COVID-19 patients had an early antiviral response but became indistinguishable on a gene expression level from non-COVID-19 sepsis patients a week later. Early treatment of COVID-19 and non-COVID-19 sepsis ICU patients should focus on pathogen control, but both patient groups also require novel immunomodulatory treatments, particularly later during ICU hospitalization, independent of admission diagnosis. Some T1 samples were uploaded in GSE185263 and were not re-uploaded in this series.

2023-03-24 | GSE222393 | GEO

Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae

Project description:Post-acute sequelae of COVID-19 (PASC) represent an emerging global crisis. However, quantifiable risk-factors for PASC and their biological associations are poorly resolved. We executed a deep multi-omic, longitudinal investigation of 309 COVID-19 patients from initial diagnosis to convalescence (2-3 months later), integrated with clinical data, and patient-reported symptoms. We resolved four PASC-anticipating risk factors at the time of initial COVID-19 diagnosis: type 2 diabetes, SARS-CoV-2 RNAemia, Epstein-Barr virus viremia, and specific autoantibodies. In patients with gastrointestinal PASC, SARS-CoV-2-specific and CMV-specific CD8+ T cells exhibited unique dynamics during recovery from COVID-19. Analysis of symptom-associated immunological signatures revealed coordinated immunity polarization into four endotypes exhibiting divergent acute severity and PASC. We find that immunological associations between PASC factors diminish over time leading to distinct convalescent immune states. Detectability of most PASC factors at COVID-19 diagnosis emphasizes the importance of early disease measurements for understanding emergent chronic conditions and suggests PASC treatment strategies.

2022-02-01 | E-MTAB-10129 | biostudies-arrayexpress

undefined

Project description:Gut microbiota across early stages of alpha-synucleinopathy

| PRJEB52086 | ENA